| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |